The CHU Razi hospital in Tunis has been accredited by the World Health Organization as a regional center for Alzheimer's research and training. The accreditation was announced on September 20, 2026, by Dr. Riadh Gouider, head of the neurology department at the hospital. The center will serve as a hub for research and training in the field of dementia and Alzheimer's disease, not only for Tunisia but also for the broader Mediterranean region.
According to Dr. Gouider, several factors can contribute to the development of Alzheimer's disease, including heart disease, diabetes, and high blood pressure. Additionally, genetic characteristics common in the Arab region, such as consanguineous marriages, can also play a role in the onset and progression of the disease. Dr. Gouider emphasized that Alzheimer's is a complex condition that results from the interaction of genetic and environmental factors.
The neurology department at CHU Razi is currently conducting a case-control study on Alzheimer's disease, which has found a strong link between certain pathological and behavioral factors and the risk of developing the disease. The study, which involved 155 patients and 310 healthy individuals, identified cardiovascular disease, illiteracy, and psychological disorders as key risk factors. The findings highlight the importance of early intervention and prevention in reducing the risk of Alzheimer's.
Dr. Gouider stressed that controlling modifiable risk factors, such as high blood pressure, diabetes, and heart health, is crucial in preventing and managing Alzheimer's disease. He also recommended cognitive stimulation, education, and a healthy diet, as well as avoiding alcohol, smoking, and substance abuse. Furthermore, Dr. Gouider encouraged people aged 30-50 to prioritize their health and manage risk factors before it's too late.
The doctor also emphasized the importance of staying intellectually and physically active, particularly in older age. He warned that a sedentary lifestyle and lack of mental stimulation can increase the risk of Alzheimer's by up to eight times. Moreover, Dr. Gouider highlighted the need for integrated medical and therapeutic care, including prevention, early diagnosis, and treatment, as well as social and psychological support for patients and their families.
The accreditation of the CHU Razi center was witnessed by Tunisian Health Minister Mustapha Ferjani, who expressed his support for the hospital's research and training initiatives. The center's experience and activities were also showcased during the accreditation announcement, which coincided with World Alzheimer's Day on September 21.
The CHU Razi center is expected to play a significant role in promoting research and training in Alzheimer's disease and dementia in the region. While modern treatments for Alzheimer's are available, they are often expensive and not widely accessible in Tunisia. The center's focus on non-pharmacological therapies, such as music, art, and cultural activities, may provide a more accessible and effective approach to managing the condition.
Key points
- The CHU Razi hospital has been accredited by the World Health Organization as a regional center for Alzheimer's research and training.
- The accreditation was announced on September 20, 2026, by Dr. Riadh Gouider, head of the neurology department at the hospital.
- The center will serve as a hub for research and training in the field of dementia and Alzheimer's disease in the Mediterranean region.
